Company / Operating Income per Share
Axsome Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.43
FY2025
5-year range
-$5.93 / -$3.32
FY2021-FY2025
Trend
+42.2%
vs FY2024
Sector context
#148 of 201
Health Care
What the data says
At $-3.43, Axsome Therapeutics, Inc.'s operating income per share ranks #148 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 7 years of decline, reaching $-3.43.
Based on SEC 10-K filings.
-3.43 in FY2025.
Improved from $-5.33 to $-3.43 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#148 of 201 in Health CareTop 74% of 201This company -$3.43 Sector average -$28.56
▼
+88.0% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 42.2% year-over-year.
- Ranks #148 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.43 | +42.2% |
| FY2024 | -$5.93 | -11.2% |
| FY2023 | -$5.33 | -12.1% |
| FY2022 | -$4.75 | -43.4% |
| FY2021 | -$3.32 | -24.4% |
| FY2020 | -$2.66 | -34.8% |
| FY2019 | -$1.98 | -61.8% |
| FY2018 | -$1.22 | -2.4% |
| FY2017 | -$1.19 | +17.0% |
| FY2016 | -$1.44 | -86.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026